Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.81M Buy
26,941
+12,545
+87% +$836K 0.02% 353
2026
Q1
$904K Buy
+14,396
New +$1M 0.02% 346
2025
Q2
Sell
-154
Closed -$10.5K 205
2025
Q1
$10.5K Buy
+154
New +$12.6K 0.06% 306

Other funds holding DXCM

Saudi Central Bank's DXCM Position: Q2 2026 in Review

Saudi Central Bank increased its DexCom (DXCM) stake by 87% in Q2 2026, buying an estimated $836K and bringing the position to 26,941 shares worth $1.81M. The position accounts for 0.02% of the portfolio, ranked #353.

Saudi Central Bank first reported a position in DXCM in Q1 2025 and has held it in 3 quarters since. 327 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Saudi Central Bank held 26,941 shares of DexCom worth $1.81M as of Q2 2026.
  • Saudi Central Bank bought 12,545 DexCom shares in Q2 2026, an estimated $836K.
  • DexCom made up 0.02% of Saudi Central Bank's portfolio in Q2 2026, its #353 holding.
  • Saudi Central Bank first reported a position in DexCom in Q1 2025 and has held it in 3 quarters since.
  • 327 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Saudi Central Bank's 13F filing for Q2 2026, filed 30 Jul 2026.